CLINICAL_TRIALS
trial_result
· 2021-02-11
Clinical Trial Update: Perioperative Dexamethasone on Postoperative Outcome in IBD [Phase 2]
Summary
Phase 2 trial update examining perioperative dexamethasone to improve postoperative outcomes in inflammatory bowel disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jinling Hospital, China | Conditions: Inflammatory Bowel Diseases, Dexamethasone | Phase 2 | Status: COMPLETED